# EquipmentShare (EQPT) — Investment Thesis

**Exchange:** NASDAQ  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-10  
**Tier:** Free primer (steps 1 & 3 of 19)  
**Sibling pages:** /stocks/EQPT/financials · /stocks/EQPT/memo

> This page shows the free thesis context (business model + recent catalysts).
> The full investment thesis (moat analysis, DCF, scenarios, risk register) is available
> via GET /api/v1/research/EQPT/memo ($2.00, Bearer token).

## Recent Catalysts

# Step 15 — Scenario, Stress, and Base-Rate Analysis

## Key Findings

**Net direction for thesis:** Moderately negative. Scenario analysis reveals a wide outcome distribution ($12-45 per share range) with asymmetric near-term downside driven by the lockup unlock and active securities investigations. Base rates for recent similar controlled-company IPOs with governance concerns (Palantir 2020, Snowflake 2020, Coinbase 2021) are mixed — none cleanly comparable. The most appropriate analog is **Rivian (2021 IPO)**: controlled structure, hype-driven IPO, post-IPO disclosure events, stock cratered -70% from peak over 2-3 years as fundamentals were reassessed. EquipmentShare's fundamentals are better than Rivian's were, but the path-of-price pattern is recognizable.

Monte Carlo not used — deterministic scenarios are sufficient given the binary nature of the governance events.

**Key Kahneman bias flags identified:**
- **Anchoring on IPO first-day close ($32.56):** Investors anchor on the peak-momentum price; base-rate says most IPOs that pop +30% decline from that peak within 12 months
- **Saliency of T3/OWN "platform thesis":** Makes the narrative feel more differentiated than the balance sheet suggests
- **Planning fallacy on mature-site ramp:** Management's 24-month maturation is narratively clean but unverified at scale
- **Groupthink (9 analysts at "Buy"):** Consensus is stale and likely anchored to pre-March 18 disclosure
- **Competitor neglect (URI counter-response):** Scenarios must include URI launching competing T3-equivalent platform within 2-3 years

---

## Scenarios

### Scenario 1: Bull — "Thesis Validates" (Probability: 25%)

**Drivers:**
- FY2026 revenue beats mid-guide to $5.40B+ (+23%+ growth)
- FY2026 Adj EBITDA clean beats analyst estimate to $1.75B+
- Chheda case dismissed or settled without material findings
- No short-seller report published
- OWN Program regulatory all-clear
- Mature-site economics confirmed across 8 quarters
- Sell-side analyst target revisions converge around $35-45

**Fair value:**
- DCF base case: ~$35
- Multiple-based (8x FY2027E clean EBITDA $2.0B): ~$45
- **Target: $38-45**

**Path:**
- Q1 2026 solid (~mid-May 2026)
- Q2 2026 solid, lockup unlock absorbed quietly (~July 2026)
- Q3 2026 solid, growth rate stabilizing mid-20s (~Nov 2026)
- FY2026 full-year meets or exceeds guide (Feb 2027)
- Valuation re-rates into FY2027 earnings delivery

### Scenario 2: Base — "Mixed Execution" (Probability: 40%)

**Drivers:**
- FY2026 revenue meets or slightly misses mid-guide
- FY2026 Adj EBITDA misses reported $1.87B mid-guide by 5-10% (clean equivalent $1.60-1.70B)
- Chheda case slowly grinds; settlement or dismissal in 2027-2028
- One short-seller report published mid-2026; stock absorbs over 3 months
- Lockup unlock produces modest selling pressure; stock down 10-15% over July-September 2026
- Multiple stays at 5-6x EV/EBITDA

**Fair value:**
- DCF base case with moderate governance overhang: ~$28
- Multiple-based at 6x FY2027E clean: ~$32
- **Target: $26-32**

**Path:**
- Q1 2026 meets guide within 3% (~mid-May 2026)
- Lockup unlock chops stock 10-15% over July-Sept 2026
- Q3 2026 guidance reiteration but at mid- to low-end of original range
- FY2026 lands at lower end of guide
- FY2027 growth decelerates to +15%; multiple compresses slightly

### Scenario 3: Bear — "Thesis Breaks" (Probability: 35%)

**Drivers:**
- Short-seller report published (probability 65% per Step 11) with new documentation
- Formal securities class action filed (probability 65% per Step 04)
- One or more SEC / FINRA inquiries
- Lockup unlock triggers coordinated VC selling over 30-60 days, -20-30% mechanical move
- Fundamental misses compound: Q2 or Q3 2026 EBITDA misses guide by 10%+
- Sell-side downgrades to "Hold" or "Sell"
- Governance discount widens to 30%+
- Multiple compresses to 4.5-5.5x

**Fair value:**
- DCF with 30% governance discount + class-action overhang: ~$18
- Multiple-based at 5x FY2027E clean ($1.8B if missed guide): ~$12
- **Target: $12-18**

**Path:**
- Stock bleeds to $18 by July (lockup + class-action reactions)
- July 23 unlock + coordinated VC selling drive stock to $14-16 by Sept
- Q3 2026 earnings with cautious tone; stock stays $13-16
- Bottom around $12-15 in late 2026
- Gradual recovery requires Chheda resolution + clean FY2026 close

### Severe Downside: "Rivian Scenario" (~10% within Bear)

Stress test: Short-seller report + SEC enforcement + fraud finding on Schlacks-entity transactions. Would require coordinated negative events. Fair value $5-8/share (-65% to -75% from spot). Very low probability but non-zero.

---

## Lockup-Unlock Mechanical Selling (Bear Case Component)

Sized per Step 06 analysis:
- 220M shares unlock 2026-07-23
- Pre-unlock ADTV: ~2-4M shares
- Scenario: 10% of locked shares sold over 30 days = 22M shares
- Absorbing 22M shares requires ~15-25% price discount over 30 days
- This is INDEPENDENT of fundamental news — pure supply/demand

Scenario ranges:
- Mild (10% of locked sold): -8% to -12% in 30 days
- Base (20% sold): -15% to -20% in 30 days
- Severe (40% sold; panic + coordinated VC exit): -25% to -35% in 30 days

---

## Base Rate Analysis

### Recent similar IPOs — controlled-company + governance concerns

| Company | IPO Year | Controlled? | Governance Concerns | Peak Price | Price 12 mo post-IPO | Delta |
|---------|----------|-------------|---------------------|------------|----------------------|-------|
| Snowflake | 2020 | No (but supervoting founder) | Valuation | $401 | $257 | -36% |
| Palantir | 2020 | Yes (triple-class) | Karp/Thiel concerns | $39 | $17 | -56% |
| Coinbase | 2021 | Dual-class | Regulatory | $430 | $126 | -71% |
| Rivian | 2021 | Yes (dual-class) | Losses/execution | $179 | $46 | -74% |
| EquipmentShare | 2026 | Dual-class + controlled | Chheda/RPT | $32.56 | TBD | **~-34% so far (-12% from IPO offer)** |

**Base rate observation:** Post-IPO peak-to-trough drawdowns of -40% to -75% are the norm for controlled-company IPOs with governance concerns. EquipmentShare is -34% from Day-1 peak as of research date — well within the band but not at the depths of comparable drawdowns.

### Kahneman bias checklist

| Bias | Risk | Status |
|------|------|--------|
| Anchoring (on IPO first-day close $32.56) | Making current $21.48 look cheap | Flagged |
| Saliency ("T3 platform" hero narrative) | Overweighting moat claim | Flagged; Step 10 provisional-narrow |
| Planning fallacy (mature-site ramp timeline) | Assuming 24-month maturation is certain | Flagged; margin-compression in FY2026 guide |
| Groupthink (9 "Buy" analysts, consensus target $38.88) | Anchoring to underwriter-biased coverage | Flagged; expected downward revisions |
| Competitor neglect (URI T3-equivalent) | Understating replication risk | Flagged in Step 10 |
| Sunk cost (on Chheda case / governance) | Continuing to hold after deteriorating fundamentals | To guard against via exit triggers |

---

## Assumption Register Updates

| ID | Step | Assumption | Type | Value | Unit | Basis | Sensitivity | Source Tags | Basis Confidence | Pre-IPO vs Post-IPO |
|----|------|------------|------|-------|------|-------|-------------|-------------|------------------|---------------------|
| A-78 | 15 | Bull case probability | Judgment | 25 | % | Scenario analysis | High | Internal | Provisional | N/A |
| A-79 | 15 | Base case probability | Judgment | 40 | % | Scenario analysis | High | Internal | Provisional | N/A |
| A-80 | 15 | Bear case probability | Judgment | 35 | % | Scenario analysis | High | Internal | Provisional | N/A |
| A-81 | 15 | Lockup unlock base-case price impact (July 2026) | Estimate | -15 to -20 | % | Supply/demand math | High | Internal | Provisional | N/A |

---

## Tables and Calculations

### Table 1 — Scenario summary

| Scenario | Probability | Fair Value | Weighted contribution |
|----------|-------------|-----------|------------------------|
| Bull | 25% | $41 | $10.25 |
| Base | 40% | $29 | $11.60 |
| Bear | 35% | $15 | $5.25 |
| **PWFV** | | | **$27.10** |
| Current price | | $21.48 | -21% below PWFV |

### Table 2 — Timeline of scenario triggers

| Event | Date | Bull signal | Base signal | Bear signal |
|-------|------|--------------|-------------|-------------|
| Q1 2026 earnings | ~May 2026 | Beat + guide raise | Meet | Miss |
| Greenshoe outcome disclosed | Any Q1 2026 8-K | Fully exercised | Partial | Not exercised |
| Lockup unlock | July 23, 2026 | Orderly absorb | Modest pressure | Chaos |
| Q2 2026 | ~Aug 2026 | Beat | Meet | Miss |
| Chheda ruling (first motion) | 2026-2027 | Dismissal | Continuation | Adverse |
| Short-seller report | Any time | None | One, absorbed | One+ w/ documentation |
| Class action complaint | Any time | None | Filed | Filed w/ discovery |
| Q3 2026 | ~Nov 2026 | Beat + FY raise | Meet | Miss + FY cut |
| FY2026 full-year | Feb 2027 | At high end of guide | Midpoint | Below low end |

---

## Open Questions and Data Gaps

1. What is the actual pre-lockup float behavior — short interest ratio? Borrow cost?
2. Are any VC holders (Insight, BDT) signaling secondary-sale intent?
3. Is there a private secondary market for EQPT shares operating pre-unlock?

---

## Next-Step Dependencies

Step 16 (Variant + Catalysts) should enumerate specific dated catalyst events and convert Step 15 scenarios into observable CAT- / EX- row triggers.

---

## Source Index

| Source Tag | Document | Section | Date | Notes |
|------------|----------|---------|------|-------|
| [S1] | Steps 13 + 14 | Forecast + valuation | 2026-04-23 | |
| [S2] | Base-rate IPO history | External | Historical | |

## Full Investment Thesis (Premium)

The full research tier adds these thesis-critical dimensions:

- Moat Analysis — durable competitive advantages, switching costs, network effects
- Investment Thesis — variant perception, what has to be true, why market may be wrong
- Bull / Base / Bear Scenarios — probability weights, catalysts, price targets
- Risk Register — macro, competitive, execution, regulatory risks with materiality ratings
- Management Quality — capital allocation track record, incentive alignment
- DCF Valuation — 10-year model with sensitivity matrix

**API endpoint:** GET /api/v1/research/EQPT/memo

## Navigation

- Overview: /stocks/EQPT
- Financials: /stocks/EQPT/financials
- Thesis (this page): /stocks/EQPT/thesis
- Investment Memo: /stocks/EQPT/memo
- Coverage universe: /stocks